Literature DB >> 28724608

ErbB4 deletion accelerates renal fibrosis following renal injury.

Fenghua Zeng1, Tomoki Miyazawa1, Lance A Kloepfer1, Raymond C Harris1,2.   

Abstract

Tubulointerstitial fibrosis (TIF) is a prominent factor in the progression of chronic kidney disease regardless of etiology. Avian erythroblastic leukemia viral oncogene homolog 4 (ErbB4) expression levels were inversely correlated to renal fibrosis in human fibrotic kidneys. In both unilateral ureteral obstruction (UUO) and ischemia-reperfusion injury followed by uninephrectomy (IRI/UNx) mouse models, expression levels of ErbB4 were elevated in the early stage of renal injury. Using mice with global ErbB4 deletion except for transgenic rescue in cardiac tissue ( ErbB4-/-ht+), we determined that UUO induced similar injury in proximal tubules compared with wild-type mice but more severe injury in distal nephrons. TIF was apparent earlier and was more pronounced following UUO in ErbB4-/-ht+ mice. With ErbB4 deletion, UUO injury inhibited protein kinase B phosphorylation and increased the percentage of cells in G2/M arrest. There was also increased nuclear immunostaining of yes-associated protein and increased expression of phospho-Mothers against decapentaplegic homolog 3, snail1, and vimentin. These results indicate that ErbB4 deletion accelerates the development and progression of renal fibrosis in obstructive nephropathy. Similar results were found in a mouse IRI/UNx model. In conclusion, increased expression of ErbB4 in the early stages of renal injury may reflect a compensatory effect to lessen tubulointerstitial injury.

Entities:  

Keywords:  avian erythroblastic leukemia viral oncogene homolog 4; cell cycle; epithelial dedifferentiation; tubulointerstitial fibrosis

Mesh:

Substances:

Year:  2017        PMID: 28724608      PMCID: PMC6031915          DOI: 10.1152/ajprenal.00260.2017

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  36 in total

Review 1.  The ErbB signaling network: receptor heterodimerization in development and cancer.

Authors:  M A Olayioye; R M Neve; H A Lane; N E Hynes
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

2.  Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury.

Authors:  T Ichimura; J V Bonventre; V Bailly; H Wei; C A Hession; R L Cate; M Sanicola
Journal:  J Biol Chem       Date:  1998-02-13       Impact factor: 5.157

3.  Replication study for the association of 3 SNP loci identified in a genome-wide association study for diabetic nephropathy in European type 1 diabetes with diabetic nephropathy in Japanese patients with type 2 diabetes.

Authors:  Shiro Maeda; Minako Imamura; Mahiro Kurashige; Shinichi Araki; Daisuke Suzuki; Tetsuya Babazono; Takashi Uzu; Tomoya Umezono; Masao Toyoda; Koichi Kawai; Masahito Imanishi; Kazushige Hanaoka; Hiroshi Maegawa; Yasuko Uchigata; Tatsuo Hosoya
Journal:  Clin Exp Nephrol       Date:  2013-03-30       Impact factor: 2.801

4.  gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase.

Authors:  C Y Ni; M P Murphy; T E Golde; G Carpenter
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

5.  EGFR signaling promotes TGFβ-dependent renal fibrosis.

Authors:  Jianchun Chen; Jian-Kang Chen; Kojiro Nagai; David Plieth; Mingqi Tan; Tang-Cheng Lee; David W Threadgill; Eric G Neilson; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2011-11-17       Impact factor: 10.121

6.  Activation of Erk1/2 and Akt following unilateral ureteral obstruction.

Authors:  Ana B Rodríguez-Peña; Maria T Grande; Nélida Eleno; Miguel Arévalo; Carmen Guerrero; Eugerio Santos; José M López-Novoa
Journal:  Kidney Int       Date:  2008-04-30       Impact factor: 10.612

7.  Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System.

Authors:  Steven J Forrester; Tatsuo Kawai; Shannon O'Brien; Walter Thomas; Raymond C Harris; Satoru Eguchi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-11-09       Impact factor: 13.820

8.  Deletion of ErbB4 accelerates polycystic kidney disease progression in cpk mice.

Authors:  Fenghua Zeng; Tomoki Miyazawa; Lance A Kloepfer; Raymond C Harris
Journal:  Kidney Int       Date:  2014-03-26       Impact factor: 10.612

Review 9.  Mitogen activated protein kinases in renal fibrosis.

Authors:  Frank Y Ma; Mythily Sachchithananthan; Robert S Flanc; David J Nikolic-Paterson
Journal:  Front Biosci (Schol Ed)       Date:  2009-06-01

10.  Renal fibrosis is not reduced by blocking transforming growth factor-β signaling in matrix-producing interstitial cells.

Authors:  Surekha Neelisetty; Catherine Alford; Karen Reynolds; Luke Woodbury; Stellor Nlandu-Khodo; Haichun Yang; Agnes B Fogo; Chuan-Ming Hao; Raymond C Harris; Roy Zent; Leslie Gewin
Journal:  Kidney Int       Date:  2015-03-11       Impact factor: 10.612

View more
  10 in total

1.  ErbB4 deletion predisposes to development of metabolic syndrome in mice.

Authors:  Fenghua Zeng; Yinqiu Wang; Lance A Kloepfer; Suwan Wang; Raymond C Harris
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-06-26       Impact factor: 4.310

Review 2.  Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression.

Authors:  Li Gao; Xiang Zhong; Juan Jin; Jun Li; Xiao-Ming Meng
Journal:  Signal Transduct Target Ther       Date:  2020-02-14

3.  Network Pharmacology-Based Exploration of the Therapeutic Mechanisms of Cordyceps cicadae in Renal Ischemia/Reperfusion.

Authors:  Jiajun Dong; Mingyang Cao; Hui Yu; Yang Dong; Conghui Han
Journal:  Ann Transplant       Date:  2022-09-30       Impact factor: 1.479

4.  In Vivo Inhibition of TRPC6 by SH045 Attenuates Renal Fibrosis in a New Zealand Obese (NZO) Mouse Model of Metabolic Syndrome.

Authors:  Zhihuang Zheng; Yao Xu; Ute Krügel; Michael Schaefer; Tilman Grune; Bernd Nürnberg; May-Britt Köhler; Maik Gollasch; Dmitry Tsvetkov; Lajos Markó
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

Review 5.  The epidermal growth factor receptor axis and kidney fibrosis.

Authors:  Raymond C Harris
Journal:  Curr Opin Nephrol Hypertens       Date:  2021-05-01       Impact factor: 2.894

6.  Genome-Wide Reduction in Chromatin Accessibility and Unique Transcription Factor Footprints in Endothelial Cells and Fibroblasts in Scleroderma Skin.

Authors:  Pei-Suen Tsou; Pamela J Palisoc; Mustafa Ali; Dinesh Khanna; Amr H Sawalha
Journal:  Arthritis Rheumatol       Date:  2021-07-07       Impact factor: 15.483

Review 7.  Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease.

Authors:  Lili Sheng; George Bayliss; Shougang Zhuang
Journal:  Front Pharmacol       Date:  2021-01-26       Impact factor: 5.810

8.  Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling.

Authors:  Xingli Ji; Honglian Wang; Zhaojun Wu; Xia Zhong; Menglian Zhu; Yuwei Zhang; Ruizhi Tan; Yuhang Liu; Jianchun Li; Li Wang
Journal:  Med Sci Monit       Date:  2018-03-20

Review 9.  Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression.

Authors:  Li Gao; Xiang Zhong; Juan Jin; Jun Li; Xiao-Ming Meng
Journal:  Signal Transduct Target Ther       Date:  2020-02-14

10.  Associations between the concentrations of CD68, TGF-β1, renal injury index and prognosis in glomerular diseases.

Authors:  Jingshu Sun; Lihai Hao; Hongbo Shi
Journal:  Exp Ther Med       Date:  2020-09-04       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.